Skip to main content

Global Impact

Breast Cancer Worldwide

Breast cancer is the most commonly diagnosed cancer in women worldwide — 2.3 million new cases every year. The survival rate in the UK is over 85%. In low-income communities it can be below 40%. The cause of that gap is not biology. It is access.

2.3M
new cases globally each year (WHO 2022)
670,000
deaths worldwide annually
60%+
of deaths in low and middle-income countries
<40%
five-year survival in many low-income countries

The global survival gap — why it exists

The most important statistical story in global breast cancer is not incidence — it is survival. In the UK, over 85% of women diagnosed with breast cancer survive for five or more years. In many low-income countries, that figure is below 40%. In some communities it may be lower still.

This gap is not caused by biological differences between populations. The cause is structural — the absence of screening programmes, health literacy barriers, late-stage presentation, and severely limited access to treatment by cost or geography.

In the UK, NHS screening detects many breast cancers at Stage I or II, when the cancer is small, localised and highly treatable. In countries without equivalent screening programmes, most women are diagnosed at Stage III or IV — when the tumour is large, has spread to lymph nodes or distant organs, and requires more intensive treatment with a lower chance of cure.

Which countries are most affected?

High-income countries have the highest breast cancer incidence rates — partly because screening detects more cancers, and partly because of longer life expectancy and lifestyle factors. But they also have the best survival rates.

The countries with the poorest breast cancer survival are concentrated in sub-Saharan Africa, South and South-East Asia, and parts of the Middle East. In these regions, breast cancer is typically diagnosed late, access to oncology services is extremely limited, and the cost of treatment — even basic surgery and chemotherapy — is beyond most individuals' means.

In South and South-East Asia — the primary region where Breast Cancer Charity works — five-year survival rates frequently sit between 35% and 60%, compared with over 85% in the UK. This is not inevitable. With access to basic screening and early treatment, survival can be dramatically improved.

Why do women present late?

Women in low-income communities typically present with late-stage breast cancer for a combination of reasons:

  • No routine screening: Without a national mammography programme, breast cancer is rarely detected before symptoms appear. Many cancers that would be caught at Stage I or II in the UK grow to Stage III or IV before a woman seeks medical attention.
  • Health literacy barriers: Awareness of breast cancer symptoms — what to look for and why it matters — is critically low in many communities. Many women do not know that a breast lump may be cancer, or do not understand that early treatment can be curative.
  • Cultural and gender barriers: In many communities, discussions about women's bodies and health are taboo. Fear of diagnosis, fatalism, and social stigma around cancer can prevent women from seeking help even when they have noticed a change.
  • Financial barriers: Even where medical services exist, the cost of a clinic visit, biopsy, surgery and chemotherapy is prohibitive for most families in low-income settings. Medical expenses frequently exceed annual household income.
  • Geographic barriers: Specialist oncology services are concentrated in major urban centres. Women in rural areas may need to travel hundreds of kilometres for a breast clinic appointment — a journey that is practically and financially impossible for many.

What is Breast Cancer Charity doing about it?

Breast Cancer Charity — an initiative of World Aid Network — exists specifically to address this crisis. Our programmes focus on three priorities:

  • Free breast cancer screening: We fund mobile screening units, trained community health workers, and clinical breast examinations in communities that have no access to mammography. Early detection is the single most effective way to improve survival.
  • Community education: We fund community health educators to deliver awareness sessions in local languages, covering breast self-examination, warning signs, and the importance of early treatment. Ten pounds funds an awareness session for twelve women.
  • Treatment access: We fund biopsy and diagnosis for women who cannot afford clinical assessment. Twenty-five pounds funds a complete breast screening. Seventy-five pounds covers biopsy and diagnosis. One hundred and fifty pounds funds a surgical procedure.

Every £1 donated goes directly to programmes that close the survival gap. No woman should die of breast cancer because she could not afford a £25 screening test.

Frequently asked questions

What is the global breast cancer survival rate? +
The global five-year breast cancer survival rate varies dramatically between countries. In high-income countries such as the UK, USA and Australia, five-year survival exceeds 85–90%. In low-income countries, survival can be below 40%. This gap is driven primarily by late-stage diagnosis due to absent or inadequate screening, rather than biological differences between populations.
Which country has the highest rate of breast cancer? +
High-income Western countries — including Belgium, Denmark, the Netherlands, the UK and Australia — have the highest breast cancer incidence rates globally, largely due to longer life expectancy and widespread use of screening (which detects more cancers). However, high incidence does not mean poor survival: these countries also have the best survival rates because of early detection. Countries with lower incidence often have worse survival because most cancers are detected at a later, less treatable stage.
How many women die from breast cancer worldwide each year? +
According to the World Health Organization, approximately 670,000 women died from breast cancer worldwide in 2022. Over 60% of all breast cancer deaths occur in low and middle-income countries. This is not because breast cancer is more common there — it is because most women are diagnosed at Stage III or IV, when the cancer is much harder to treat.

Sources

This content is for educational purposes and does not constitute medical advice.

Close the gap — one screening at a time

The difference between 85% survival and 40% survival is not biology. It is access. Fund the access.

Fund a Free Screening — £25